Article Text

Download PDFPDF
Conservative En Bloc Surgery for Aggressive Angiomyxoma Achieves Good Local Control: Analysis of 14 Patients From a Single Institution
  1. Sarah Coppola, MD*,
  2. Anant Desai, MD,
  3. Dimitri Tzanis, MD*,
  4. Charles Honoré, MD*,
  5. Georgina Bitsakou, MD*,
  6. Cécile Le Péchoux, MD,
  7. Philippe Terrier, MD§ and
  8. Sylvie Bonvalot, MD, PhD*
  1. * From the Department of Surgery, Institut Gustave Roussy, Villejuif, France;
  2. Department of Surgery, Queen Elizabeth Hospital,Birmingham, United Kingdom; and Departments of
  3. Radiotherapy and
  4. § Pathology, Institut Gustave Roussy, Villejuif, France.
  1. Address correspondence and reprint requests to Sylvie Bonvalot, MD, PhD, Department of Surgery, Institut Gustave-Roussy, 114Rue Edouard Vaillant 94805 Villejuif Cedex France. E-mail: bonvalot{at}


Background The purpose of this study was to assess the value of conservative surgery in aggressive angiomyxoma (AA) in our institutional series.

Method This was a retrospective review of patients with AA treated at our institution between 1999 and 2010.

Results Fourteen consecutive patients were analyzed: 8 primary tumors and 6 recurrences. Female/male ratio was 13:1; median female age was 36 years. Median size of primary lesions was 12 cm (range, 7–17 cm). Median size of recurrences was 20.5 cm (range, 3–44 cm). Twelve patients were operated on. Two asymptomatic patients whose surgery would have been mutilating were placed under wait and see. Four patients had concomitant visceral resections because of massive infiltration. No tumor rupture was recorded on pathological examination. Margins were R0 (n = 2), R1 (n = 10), and R2 (n = 0). Seven patients (50%) received radiotherapy. Median postoperative follow-up was 69 months, and no patient was lost at follow-up. All patients operated on (primaries and recurrences) had no evidence of recurrence.

Conclusion Conservative and planned en bloc surgery achieves good local control with low morbidity. Radiotherapy could enhance local control in advanced disease. Wait and see is an exploratory option for asymptomatic, stable, and nonprogressing AA in which surgery would be mutilating.

  • Aggressive angiomyxoma
  • Surgery
  • Conservative treatment
  • Radiotherapy
  • Survival

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • The authors declare no conflicts of interest.